Company Filing History:
4 out of 3,539 
2 out of 31 
1 out of 1,217 
Years Active: 1998-2015
Title: Innovations and Contributions of Inventor Thomas Ried
Introduction
Thomas Ried is a prominent inventor based in Bethesda, MD, known for his significant contributions to the field of cancer research. With a total of seven patents to his name, Ried has focused on developing methods and compositions that enhance the understanding and treatment of colorectal cancer. His work has implications for both diagnostics and therapeutic strategies.
Latest Patents
Ried's latest patents include groundbreaking inventions such as the "Identification of biomarkers by serum protein profiling." This invention relates to methods for determining colorectal cancer status in a subject and includes kits designed for this purpose. Another notable patent is "Composition for detecting the response of rectal adenocarcinomas to radiochemotherapy." This invention utilized a cDNA array of 9984 genes for expression profiling in rectal adenocarcinoma, correlating expression data to chemotherapy responsiveness. A set of 54 genes was identified as differentially expressed in responders versus non-responders, which may serve as prognostic markers for treatment efficacy.
Career Highlights
Throughout his career, Thomas Ried has worked with esteemed organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and Applied Spectral Imaging Ltd. His work in these institutions has allowed him to contribute significantly to the advancement of medical research and innovation.
Collaborations
Ried has collaborated with notable colleagues such as Yuval Garini and Dario Cabib, enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
Thomas Ried's contributions to cancer research through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer diagnostics and treatment.